Answers are grounded in this paper and cite their sources.
Salmonella remains one of the leading foodborne pathogens associated with poultry production, posing significant challenges to animal health, food safety, and public health worldwide. Vaccination has become a cornerstone of preharvest Salmonella control, particularly in response to increasing concerns over antimicrobial resistance and the limitations of conventional biosecurity measures. This narrative review critically examines current advances in Salmonella vaccination in poultry, covering conventional live attenuated and inactivated vaccines alongside emerging technologies, including subunit, recombinant, nanoparticle-based, outer membrane vesicle, and self-destructive bacterial vaccines. The review further explores the roles of maternal immunity, IgY-mediated passive protection, and vaccine-associated modulation of the intestinal microbiota in enhancing resistance to Salmonella colonization. Practical challenges affecting vaccine performance, including serovar diversity, field variability, administration strategies, microbiota interactions, and commercial implementation, are also discussed within the context of integrated multi-hurdle control programs. Finally, future perspectives highlight the potential of conserved antigen discovery, precision vaccine design, microbiota-informed interventions, and One Health approaches to improve vaccine efficacy and sustainability. Collectively, current evidence indicates that vaccination is a cornerstone of comprehensive Salmonella control programs, although optimal protection depends on integration with biosecurity, management, and microbiota-directed strategies to achieve consistent reductions in pathogen transmission throughout the poultry production chain.
No takes yet. Share an insight, caveat, or question.
Naeem et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: